Login
From:
BioSpace
(Uncensored)
subscribe
Marks’ Sudden Departure From FDA Magnifies Uncertainty, Sends Biopharma Shares Down - BioSpace
https://www.biospace.com/fda/marks-sudden-departure-from-fda-magnifies-uncertainty-sends-biopharma-shares-down
links
backlinks
Tagged with:
policy
people
fda
regulatory
aggregate
The stock market—and biotech insiders—reacted negatively to the allegedly forced resignation of CBER Director Peter Marks, who said RFK Jr. does not seek “truth and transparency” but rather “subservient confirmation of his misinformation and lies.”
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
